Omega Fund Management, LLC
Follow13F filer, CIK 1637359, BOSTON, MA
Omega Fund Management, LLC reported $125,163,396 across 10 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.
Accepted , ingested 13F-HR 0001193125-26-462150
- Period
- 2026-09-30
- Reported value
- $125M
- Holdings
- 10
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| IMUXnew | +430,180 | $4M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| KMTSreduced | -659,755 | -$18.7M |
| ALMSexited | -241,255 | -$6.79M |
| BBNXreduced | -354,173 | -$6.72M |
| NUVBreduced | -930,058 | -$5.21M |
| BCAXreduced | -62,238 | -$1.16M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001193125-26-462150, largest first. % of portfolio is the value over $125,163,395, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| NUVBNUVATION BIO INC | 7,151,031 | $40M | 31.99% | -930,058 | Timeline | ||
| BCAXBICARA THERAPEUTICS INC | 1,759,912 | $32.8M | 26.17% | -62,238 | Timeline | ||
| BBNXBETA BIONICS INC | 962,010 | $18.3M | 14.59% | -354,173 | Timeline | ||
| BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 3,289,661 | $13.5M | 10.78% | 0 | Timeline | ||
| KMTSKESTRA MED TECHNOLOGIES LTD | 362,394 | $10.3M | 8.19% | -659,755 | Timeline | ||
| IMUXIMMUNIC INC | 430,180 | $4M | 3.2% | new | Timeline | ||
| SANASANA BIOTECHNOLOGY INC | 843,750 | $2.46M | 1.97% | 0 | Timeline | ||
| IMAIMAGENEBIO INC | 455,361 | $2.09M | 1.67% | 0 | Timeline | ||
| ENGNENGENE HOLDINGS INC | 876,357 | $1.75M | 1.4% | 0 | Timeline | ||
| ODTXODYSSEY THERAPEUTICS INC | 2,893 | $64.3K | 0.05% | 0 | Timeline |
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| ALMSALUMIS INC | 241,255 | $6.79M | shares |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-462150 | base | 2026-11-16 |